SynthesisBMC cancer2025
High SNHG expression may contribute to poor cervical cancer prognosis, based on systematic reviews and meta-analyses.
Synthesis in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reannotation of Public Transcriptomic Data Identifies Candidate lncRNAs and Putative Regulatory Networks in Rhabdomyosarcoma.Biomedicines · 2026Article
- Integrating Biomarkers into Cervical Cancer Screening-Advances in Diagnosis and Risk Prediction: A Narrative Review.Diagnostics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMore and more long non-coding RNA small nucleotide host RNA (SNHG) gene family has been confirmed to be unregulated in cervical cancer (CC) tissues, and it is significantly related to the prognosis of CC. The purpose of this study was to conduct a meta-analysis to explore the correlation between the expression level of SNHGs and the prognosis of CC.
methodsSix relevant electronic databases were searched, relevant original documents were screened, and the research quality of each document was assessed based on the Newcastle–Ottawa Scale (NOS) scale. Relevant data were extracted including SNHG expression levels, survival outcomes and follow-up time. Hazard ratio (HR) and Odds ratio (OR) with 95% confidence interval (CI) were combined to assess the association between SNHG expression and overall survival (OS) TNM stage, tumor size, depth of invasion. The sensitivity analyzes and Begg’s test was conducted to explore potential publication bias.
resultsThe results of pooling HR with 95%CI indicating the marked positive association between increasing SNHG expression and poor OS (HR: 2.046, 95%CI: 1.402–2.691). In addition, high SNHG expressions contribute to advanced TNM stage (OR: 1.476, 95%CI: 1.178–1.849), easier to lymph node metastasis (OR: 1.614, 95%CI: 1.021–2.553), bigger tumor size (OR: 1.299, 95%CI: 1.031–1.638). Meanwhile, an insignificant relationship was also found between high SNHGs expression and histological grade (OR: 1.053, 95%CI: 0.814–1.361), DM (OR: 1.659, 95%CI: 0.969–2.838), depth of invasion (OR: 1.126, 95%CI: 0.466–2.726) and age (OR: 1.115, 95%CI: 0.899–1.382). Sensitivity analysis suggests the reliability and robustness of OS, the results of Begg’s test indicated that there is no significant publication bias in the original literature.
conclusionMost SNHGs are highly expressed in CC tissues, elevated SNHG expression predicts poor prognosis of CC, SNHG may serve as a potential target for tumor therapy and a promising prognostic marker.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.